AzTrials
AzTrials

Laparoscopic Cholecystectomy SurgeryNCT07507292

Cystic Artery Dissection With Dorsal Infundibular Approach Versus Critical View of Safety

A study testing critical view of saftey and cystic artery dissection with dorsal infundibular dissection in people with Laparoscopic Cholecystectomy Surgery, run by Zagazig University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

We evaluated the efficacy of combining cystic artery dissection with a dorsal infundibular approach in comparison to the critical view of safety. By analyzing these techniques, we aim to refine laparoscopic cholecystectomy protocols and enhance patient safety by minimizing bile duct complications Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Laparoscopic Cholecystectomy Surgery
What is being tested?
critical view of saftey and cystic artery dissection with dorsal infundibular dissection
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
300 participants
Where
1 siteEgypt
Study dates
22 Dec 2022to 22 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • the study included adult patients who were candidates for laparoscopic cholecystectomy.
  • Exclusion criteria: patients who were unfit for surgery, patients with acute cholecystitis, and patients who refused to participate in the study

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Zagazig Univeesity Hospitals

    Zagazig, Sharqia Province

Other trials in Egypt

About this study

Official title: Cystic Artery Dissection With Dorsal Infundibular Approach Versus Critical View of Safety: A Prospective Randomized Study Optimizing Outcomes in Laparoscopic Cholecystectomy

We evaluated the efficacy of combining cystic artery dissection with a dorsal infundibular approach in comparison to the critical view of safety. By analyzing these techniques, we aim to refine laparoscopic cholecystectomy protocols and enhance patient safety by minimizing bile duct complications

Being tested
critical view of saftey, cystic artery dissection with dorsal infundibular dissection

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • critical view of safteyProcedure or surgery

    Achievement of the Critical View of Safety (CVS) requires the completion of three mandatory criteria prior to the application of clips: first, the complete clearance of all fibro-fatty tissue from the hepatocystic triangle; second, the mobilization of the lower pole of the gallbladder from the liver bed to expose at least the inferior third of the cystic plate; and finally, the clear demonstration of exactly two structures-the cystic duct and cystic artery-entering the gallbladder. Only upon definitive visualization of these components is the CVS considered achieved

  • cystic artery dissection with dorsal infundibular dissectionProcedure or surgery

    Following optimized gallbladder retraction and identification of the Rouviere's sulcus, any existing adhesions were cleared via a combination of blunt and sharp dissection. The procedure commenced with a peritoneal incision on the right lateral aspect at the cysto-infundibular junction, facilitating lateral retraction of the infundibulum and opening of the hepatocystic (Calot's) triangle. Subsequently, the left-sided peritoneum was incised along the anterior border of the cystic artery, extending over the inferior fourth of the gallbladder. Precise hemostasis was maintained, particularly at the ductal branches, to ensure a clear operative field. Connecting the bilateral peritoneal incisions ventrally facilitated the creation of a retro-ductal window. This maneuver allowed for superior retraction of the infundibulum away from the common bile duct, effectively straightening the cystic duct for safer identification

Study groups in NCT07507292
Study groupRoleWhat they receive
critical view of safteyActive comparatordissection was conducted to provide the critical view of safety prior to the clipping and division of the cystic duct and artery
Receives: Procedure: critical view of saftey
cystic artery dissection with dorsal infundibular dissection (CADID)Experimentalby identification and dissection of the cystic artery along with dorsal infundibular dissection with maintaining the integrity of the hepatocystic triangle
Receives: Procedure: cystic artery dissection with dorsal infundibular dissection

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. rate of iatrogenic bike duct unjury

    Measured: Biliary Tract Injury will be monitored from the start of the surgical procedure through the 30-day postoperative follow-up period. This includes all intraoperative detections and any delayed presentations (leaks or strictures) confirmed via biochemical

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Apr 2026
  2. Study start22 Dec 2022
  3. Primary completion22 Dec 2023
  4. Study completion22 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
300 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07507292
Sponsor's protocol ID
Cystic Artery Dissection
Status last verified
Mar 2026
First submitted
27 Mar 2026
Last updated
2 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing critical view of saftey and cystic artery dissection with dorsal infundibular dissection in people with Laparoscopic Cholecystectomy Surgery, run by Zagazig University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

rate of iatrogenic bike duct unjury (time frame: Biliary Tract Injury will be monitored from the start of the surgical procedure through the 30-day postoperative follow-up period. This includes all intraoperative detections and any delayed presentations (leaks or strictures) confirmed via biochemical). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in